Warning: Undefined array key "file" in /home/www/wwwroot/HTML/www.exportstart.com/wp-content/themes/1198/header.php on line 7

Warning: Undefined array key "title" in /home/www/wwwroot/HTML/www.exportstart.com/wp-content/themes/1198/header.php on line 7

Warning: Undefined array key "title" in /home/www/wwwroot/HTML/www.exportstart.com/wp-content/themes/1198/header.php on line 7

Sorafenib Tosylate

High Quality Sorafenib Tosylate CAS 284461-73-0 for Anti-Turmor

 

  • Inoa mea kūʻai:

    Sorafenib Tosylate

  • Nā waiwai:

    White to off-white solid

  • Hoʻopili:

    1 kg/Aluminum Bag or 25 kg/Drum

  • MOQ:

    1 kg

  • Waihona:Wahi Maloo Puanu



Nā kikoʻī

Nā huaʻōlelo

Hōʻike huahana

Sorafenib is a new multitarget oral drug for the treatment of cancer. It is used to treat gastrointestinal stromal tumors and metastatic kidney cells that do not respond to or tolerate standard therapies. It selectively targets certain protein receptors and is thought to act as a molecular switch during tumor growth. Its above indications have been granted "fast track" approval status by the FDA in the United States.

 

Nā hiʻohiʻona

Appearance and properties: white to off-white solid
Density: 1.454 g/cm3
Melting point: 202-204°C
Boiling point: 523.3ºC at 760 mmHg
Flash point: 270.3ºC
Vapor pressure: 4.76E-11mmHg at 25°C

 

Palapala noi

Sorafenib is a novel, multi-targeted oral tumor agent for the treatment of inoperable or distant metastatic hepatocellular carcinoma.

 

Nā pono

Loaʻa iā mākou nā hale hana kiʻekiʻe me ka pilina hohonu, hiki iā ia ke hāʻawi iā ʻoe i nā huahana kiʻekiʻe a me nā kumukūʻai hoʻokūkū. A hiki iā mākou ke hāʻawi i nā uku no nā kūʻai nui. A ke hui pū nei mākou me nā ʻoihana lawe ukana ʻoihana he nui, hiki ke hāʻawi i nā huahana me ka palekana a me ka maʻalahi i kou mau lima. ʻO ka manawa hoʻouna ma kahi o 3-20 mau lā ma hope o ka hōʻoia ʻana o ka uku.

 

Hōʻike

 

Product knowledge

1. Treatment of inoperable or distant metastatic liver tumor cells.
​2. Treatment of inoperable renal tumor cells.
​3. Treatment of locally relapsed or metastatic, progressively differentiated thyroid patients who no longer respond to radioiodine therapy.

 

Hoʻouna a me ka uku

 

FAQ

 

1. He hale hana ʻoe a he hui kālepa paha?
He compnay mākou e hoʻohui i ka ʻoihana a me ke kālepa, e hāʻawi ana i ka lawelawe hoʻokahi. Hiki ke ʻae ʻia ʻo OEM.

 

2. Hāʻawi anei ʻoe i nā laʻana? He manuahi a keu paha?
Free samples.The sample's freight fee Pono e uku ma kou aoao.

 

3. Loaʻa iā ʻoe nā palapala hōʻoia e pili ana i ka mana maikaʻi?
ISO 9001: 2008 palapala hōʻoia e hōʻoia i ka maikaʻi.

 

4. He aha kaʻu e hāʻawi ai e kiʻi i kahi ʻōlelo?
E haʻi mai ʻo Pls iā mākou i ke ʻano huahana āu e pono ai, ka nui o ke kauoha, ka helu a me nā koi kikoʻī. E hana ʻia ka ʻōlelo no kāu kuhikuhi i ka manawa.

 

5. He aha ke ʻano o ka uku uku āu e makemake ai? He aha ke ʻano o nā ʻōlelo i ʻae ʻia?
ʻAe ʻia nā ʻōlelo hoʻouna: FOB, CFR, CIF, EXW;
ʻAe ʻia ke kālā uku:USD;
ʻAno uku i ʻae ʻia: T / T, Western Union; Paypal, Hōʻoia Kūʻai.
ʻŌlelo i ʻōlelo ʻia: English.

 

Inā makemake ʻoe i kā mākou huahana, hiki iā ʻoe ke koho e waiho i kāu ʻike ma aneʻi, a e hoʻopili koke mākou iā ʻoe.


E kākau i kāu leka ma aneʻi a hoʻouna mai iā mākou